Barriers and strategies to achieve a cure for HIV

被引:98
|
作者
Pitman, Matthew C. [1 ,2 ]
Lau, Jillian S. Y. [3 ]
McMahon, James H. [3 ,4 ]
Lewin, Sharon R. [1 ,2 ,3 ]
机构
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
[4] Monash Med Ctr, Dept Infect Dis, Clayton, Vic, Australia
来源
LANCET HIV | 2018年 / 5卷 / 06期
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会; 美国国家卫生研究院;
关键词
CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; TREATMENT INTERRUPTION; IN-VIVO; BISPECIFIC ANTIBODIES; POSTTREATMENT CONTROL; HIV-1-INFECTED CELLS; INFECTED INDIVIDUALS; VIRAL RESERVOIR;
D O I
10.1016/S2352-3018(18)30039-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
9 years since the report of a cure for HIV after C-C chemokine receptor type 5.32 stem cell transplantation, no other case of HIV cure has been reported, despite much research. However, substantial progress has been made in understanding the biology of the latent HIV reservoir, and in measuring the amount of virus that persists after antiretroviral therapy (ART) with increasingly sophisticated approaches. This knowledge is being translated into a long pipeline of clinical trials seeking to reduce viral persistence in participants on suppressive treatment and ultimately to allow safe cessation of ART. In this Review, we discuss the main barriers preventing the development of an HIV cure, methods used to measure HIV persistence in individuals on ART, clinical strategies that aim to cure HIV, and future directions for studies in the field of HIV cure research.
引用
收藏
页码:E317 / E328
页数:12
相关论文
共 50 条
  • [41] On the way to find a cure: Purging latent HIV-1 reservoirs
    Schwartz, Christian
    Bduchat, Sophie
    Marban, Celine
    Gautier, Virginie
    Van Lint, Carine
    Rohr, Olivier
    Le Douce, Valentin
    BIOCHEMICAL PHARMACOLOGY, 2017, 146 : 10 - 22
  • [42] Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
    Apetoh, L.
    Ladoire, S.
    Coukos, G.
    Ghiringhelli, F.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1813 - 1823
  • [43] Clinical pharmacology in HIV cure research - what impact have we seen?
    Giacomelli, Andrea
    de Rose, Sonia
    Rusconi, Stefano
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (01) : 17 - 29
  • [44] Tumor exploits alternative strategies to achieve vascularization
    Bussolati, Benedetta
    Grange, Cristina
    Camussi, Giovanni
    FASEB JOURNAL, 2011, 25 (09) : 2874 - 2882
  • [45] Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue
    Boritz, Eli A.
    Douek, Daniel C.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 : S128 - S133
  • [46] Targeting HIV Transcription: The Quest for a Functional Cure
    Mousseau, Guillaume
    Mediouni, Sonia
    Valente, Susana T.
    FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 121 - 145
  • [47] Trying to cure HIV with immunotherapy: not so simple
    Kent, Stephen J.
    LANCET HIV, 2015, 2 (03): : E72 - E73
  • [48] Towards an HIV cure: a global scientific strategy
    Deeks, Steven G.
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (08) : 607 - 614
  • [49] Ethics of HIV and hepatitis B cure research
    Sugarman, Jeremy
    CURRENT OPINION IN HIV AND AIDS, 2020, 15 (03) : 180 - 184
  • [50] Possible Clues to a Functional Cure for HIV Infection
    Lai, Yu
    INTERVIROLOGY, 2015, 58 (03) : 181 - 183